Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study
Author:
Publisher
Elsevier BV
Subject
General Medicine
Reference45 articles.
1. Obesity prevalence from a European perspective: a systematic review;Berghofer;BMC Public Health,2008
2. The obesity epidemic, metabolic syndrome and future prevention strategies;James;Eur J Cardiovasc Prev Rehabil,2004
3. Prevention conference VII: Obesity, a worldwide epidemic related to heart disease and stroke: Group I: worldwide demographics of obesity;York;Circulation,2004
4. Mechanisms linking obesity with cardiovascular disease;Van Gaal;Nature,2006
5. Atlas of heart disease and stroke;Mackay,2004
Cited by 875 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The Role of Obesity in Type 2 Diabetes Mellitus—An Overview;International Journal of Molecular Sciences;2024-02-04
2. Treatment of obesity with medications binding the glucagon-like peptide 1 receptor: what is the current state of play?;Expert Opinion on Pharmacotherapy;2024-02
3. Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists on Body Weight and Cardiometabolic Parameters in Individuals With Obesity and Without Diabetes: A Systematic Review and Meta-Analysis;Endocrine Practice;2024-02
4. Efficacy and safety of GLP-1RAs for people with obesity: A systematic review based on RCT and Bayesian network meta-analysis;Biomedicine & Pharmacotherapy;2024-02
5. Glucagon-like peptide-1 receptor agonists modestly reduced blood pressure among patients with and without diabetes mellitus: A meta-analysis and meta-regression;2024-01-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3